The role of teicoplanin in the treatment of SARS‐CoV‐2 infection: A retrospective study in critically ill COVID‐19 patients (Tei‐COVID study)Giancarlo Ceccarelli, Mario Venditti, Elena Rastrelli et al.|Journal of Medical Virology|2021Cited by 24
Superinfections in patients treated with Teicoplanin as anti‐SARS‐CoV‐2 agentGiancarlo Ceccarelli, Mario Venditti, Francesco Alessandri et al.|European Journal of Clinical Investigation|2020Cited by 14
CASE REPORT: Long-term Remission of Human Immunodeficiency Virus- associated Visceral Leishmaniasis after Initiation of Potent Combination Antiretroviral Treatment: Report of Two CasesClaudio Maria Mastroianni, Vincenzo Vullo, P Santopadre et al.|Journal of Infection|2000Cited by 10